{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:06Z","timestamp":1792783686746,"version":"4.5.0"},"reference-count":389,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA_POR\/2011\/84"],"award-info":[{"award-number":["HRA_POR\/2011\/84"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005622","name":"Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["15\/CDA\/3629"],"award-info":[{"award-number":["15\/CDA\/3629"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["13\/RC\/2073"],"award-info":[{"award-number":["13\/RC\/2073"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tendon Therapy Train Project","award":["676338"],"award-info":[{"award-number":["676338"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.addr.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:47:35Z","timestamp":1535640455000},"page":"37-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"special_numbering":"C","title":["Current and upcoming therapies to modulate skin scarring and fibrosis"],"prefix":"10.1016","volume":"146","author":[{"given":"Jo\u00e3o Q.","family":"Coentro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Raghunath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios I.","family":"Zeugolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2018.08.009_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1524-475X.1994.20411.x","article-title":"Scarless human fetal skin repair is intrinsic to the fetal fibroblast and occurs in the absence of an inflammatory response","volume":"2","author":"Lin","year":"1994","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb0010","first-page":"17","article-title":"Inflammation in chronic wounds","author":"Zhao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2013","key":"10.1016\/j.addr.2018.08.009_bb0015","first-page":"423147","article-title":"Models of abnormal scarring","author":"Seo","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2018.08.009_bb0020","series-title":"Comprehensive Biomaterials","first-page":"467","article-title":"Skin tissue engineering","author":"Zeng","year":"2011"},{"key":"10.1016\/j.addr.2018.08.009_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.burns.2013.11.010","article-title":"New molecular medicine-based scar management strategies","volume":"40","author":"Arno","year":"2014","journal-title":"Burns"},{"key":"10.1016\/j.addr.2018.08.009_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00011-015-0806-0","article-title":"Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis","volume":"64","author":"Huang","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.13.173","article-title":"Potential use of TNF-alpha inhibitors in systemic sclerosis","volume":"6","author":"Murdaca","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.addr.2018.08.009_bb0040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00018-015-2110-0","article-title":"The myofibroblast, a key cell in normal and pathological tissue repair","volume":"73","author":"Darby","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0050","doi-asserted-by":"crossref","first-page":"E2162","DOI":"10.1073\/pnas.1603534113","article-title":"Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers","volume":"113","author":"Hsia","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.08.009_bb0055","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar2080","article-title":"Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes","volume":"8","author":"Bauer","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb0060","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0065","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(01)06532-1","article-title":"Hair follicle dermal sheath cells: unsung participants in wound healing","volume":"358","author":"Jahoda","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2018.08.009_bb0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-007-0008-z","article-title":"New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma","volume":"9","author":"Abraham","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.addr.2018.08.009_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00371799","article-title":"Analysis of the age-related composition of human skin collagen and collagens synthesized by fibroblast culture","volume":"286","author":"Brinckmann","year":"1994","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0080","series-title":"Reference Module in Materials Science and Materials Engineering","first-page":"332","article-title":"Collagen \u2013 materials analysis and implant uses","author":"Sorushanova","year":"2017"},{"key":"10.1016\/j.addr.2018.08.009_bb0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","article-title":"Collagen structure and stability","volume":"78","author":"Shoulders","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.addr.2018.08.009_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.276.5309.75","article-title":"Wound healing\u2014aiming for perfect skin regeneration","volume":"276","author":"Martin","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.addr.2018.08.009_bb0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004630-199509000-00013","article-title":"The vancouver scar scale: an administration tool and its interrater reliability","volume":"16","author":"Baryza","year":"1995","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.addr.2018.08.009_bb0100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/PRS.0b013e3181e6046b","article-title":"Current tools for noninvasive objective assessment of skin scars","volume":"126","author":"Perry","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.129959","article-title":"Surgical scar revision: an overview","volume":"7","author":"Garg","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.addr.2018.08.009_bb0110","doi-asserted-by":"crossref","first-page":"7018393","DOI":"10.1155\/2017\/7018393","article-title":"Ischemia\/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists","volume":"2017","author":"Neri","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.addr.2018.08.009_bb0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0125","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-induced fibrosis: mechanisms and implications for therapy","volume":"141","author":"Straub","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.addr.2018.08.009_bb0130","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0135","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.08.009_bb0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: when epithelial cells decide to become mesenchymal-like cells","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.08.009_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm0111-18","article-title":"Scarred by disease","volume":"17","author":"Hayden","year":"2011","journal-title":"Nat. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.addr.2018.08.009_bb0150","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.addr.2018.08.009_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000131502","article-title":"Scleroderma","volume":"10","author":"Gilliam","year":"2008","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.addr.2018.08.009_bb0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/art.39443","article-title":"Resolution of skin fibrosis by neutralization of the antifibrinolytic function of plasminogen activator inhibitor 1","volume":"68","author":"Lemaire","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis\u2014a lethal component of systemic sclerosis","volume":"10","author":"Ho","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0175","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","article-title":"Keloids and hypertrophic scars","volume":"43","author":"Berman","year":"2017","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0180","first-page":"744","article-title":"Quelques recherches sur la cheloide","author":"Alibert","year":"1817","journal-title":"Mem. Soc. Medicale d'Emulation"},{"key":"10.1016\/j.addr.2018.08.009_bb0185","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","article-title":"The hidden cost of skin scars: quality of life after skin scarring","volume":"61","author":"Brown","year":"2008","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0305-4179(03)00067-6","article-title":"What is the prevalence of hypertrophic scarring following burns?","volume":"29","author":"Bombaro","year":"2003","journal-title":"Burns"},{"key":"10.1016\/j.addr.2018.08.009_bb0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0973-029X.110701","article-title":"Keloid: a case report and review of pathophysiology and differences between keloid and hypertrophic scars","volume":"17","author":"Hunasgi","year":"2013","journal-title":"J. Oral Maxillofac Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00006534-199910000-00031","article-title":"On the nature of hypertrophic scars and keloids: a review","volume":"104","author":"Niessen","year":"1999","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0205","series-title":"Rook's Textbook of Dermatology, 4 Volume Set","author":"Griffiths","year":"2016"},{"key":"10.1016\/j.addr.2018.08.009_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/CCID.S35252","article-title":"Management of keloids and hypertrophic scars: current and emerging options","volume":"6","author":"Gauglitz","year":"2013","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PRS.0000000000000911","article-title":"Intralesional cryotherapy for treatment of keloid scars: a prospective study","volume":"135","author":"van Leeuwen","year":"2015","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000000357","article-title":"Surgical excision with adjuvant irradiation for treatment of keloid scars: a systematic review","volume":"3","author":"van Leeuwen","year":"2015","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"10.1016\/j.addr.2018.08.009_bb0225","author":"Renovo"},{"key":"10.1016\/j.addr.2018.08.009_bb0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/09546634.2014.906034","article-title":"Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients","volume":"26","author":"Shin","year":"2015","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.addr.2018.08.009_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2013.03.005","article-title":"Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions","volume":"70","author":"Canady","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1468-3083.2011.04206.x","article-title":"Biomarkers for skin involvement and fibrotic activity in scleroderma","volume":"26","author":"Moinzadeh","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.addr.2018.08.009_bb0245","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11926-013-0404-5","article-title":"Quantitating skin fibrosis: innovative strategies and their clinical implications","volume":"16","author":"Abignano","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.addr.2018.08.009_bb0250","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/art.22093","article-title":"Durometry for the assessment of skin disease in systemic sclerosis","volume":"55","author":"Kissin","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/rheumatology\/kem307","article-title":"High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease","volume":"47","author":"Hesselstrand","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.addr.2018.08.009_bb0265","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/1744666X.2013.848792","article-title":"Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development","volume":"9","author":"Castelino","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0270","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/rheumatology\/kei088","article-title":"Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score","volume":"44","author":"Dziadzio","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.addr.2018.08.009_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hci078","article-title":"N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma","volume":"98","author":"Dziadzio","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.addr.2018.08.009_bb0280","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar1454","article-title":"Elevated matrix metalloproteinase-9 in patients with systemic sclerosis","volume":"7","author":"Kim","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1523-1747.1998.00073.x","article-title":"Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype","volume":"110","author":"Kawakami","year":"1998","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb0290","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2133.1970.tb15741.x","article-title":"Skin collagen content and thickness in systemic sclerosis","volume":"83","author":"Black","year":"1970","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0295","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/ard.2007.082099","article-title":"COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker","volume":"67","author":"Hesselstrand","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-013-1417-7","article-title":"Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis","volume":"306","author":"Babalola","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0305","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/jid.2009.318","article-title":"A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity","volume":"130","author":"Sargent","year":"2010","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000339613","article-title":"Wound repair and regeneration","volume":"49","author":"Reinke","year":"2012","journal-title":"Eur. Surg. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0315","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.jid.5700811","article-title":"The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair","volume":"127","author":"Stramer","year":"2007","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb0320","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.08.009_bb0325","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrd4592","article-title":"Dissecting fibrosis: therapeutic insights from the small-molecule toolbox","volume":"14","author":"Nanthakumar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.08.009_bb0330","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.imbio.2011.01.001","article-title":"Macrophages in skin injury and repair","volume":"216","author":"Mahdavian Delavary","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.addr.2018.08.009_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.addr.2018.08.009_bb0340","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.08.009_bb0345","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0350","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fimmu.2015.00602","article-title":"Macrophages during the fibrotic process: M2 as friend and foe","volume":"6","author":"Braga","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0355","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1517\/14728222.11.11.1473","article-title":"Targeting selectins and selectin ligands in inflammation and cancer","volume":"11","author":"Barthel","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.addr.2018.08.009_bb0360","author":"Hospital"},{"key":"10.1016\/j.addr.2018.08.009_bb0365","author":"AB"},{"key":"10.1016\/j.addr.2018.08.009_bb0370","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/01616412.1998.11740538","article-title":"Humanized anti-L-selectin monoclonal antibody DREC200 therapy in acute thromboembolic stroke","volume":"20","author":"Bednar","year":"1998","journal-title":"Neurol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0375","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nm0402-366","article-title":"Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation","volume":"8","author":"Schon","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0380","author":"AG"},{"key":"10.1016\/j.addr.2018.08.009_bb0385","author":"AG"},{"key":"10.1016\/j.addr.2018.08.009_bb0390","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4049\/jimmunol.1600465","article-title":"BLT1 mediates bleomycin-induced lung fibrosis independently of neutrophils and CD4+ T cells","volume":"198","author":"Lv","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0395","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.4049\/jimmunol.1302959","article-title":"Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis","volume":"192","author":"Sumida","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0400","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20052349","article-title":"A unique requirement for the leukotriene B(4) receptor BLT1 for neutrophil recruitment in inflammatory arthritis","volume":"203","author":"Kim","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0405","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1183\/09031936.00143708","article-title":"Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis","volume":"34","author":"Izumo","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.08.009_bb0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.4126","article-title":"Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution","volume":"229","author":"White","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0420","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.2008.07425.x","article-title":"Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia","volume":"144","author":"Zeidler","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.addr.2018.08.009_bb0425","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/156652411795677963","article-title":"Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome","volume":"11","author":"Dotta","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0430","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI107007","article-title":"The neutrophilic leukocyte in wound repair - a study with antineutrophil serum","volume":"51","author":"Simpson","year":"1972","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.addr.2018.08.009_bb0435","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1189\/jlb.0802406","article-title":"Accelerated wound closure in neutrophil-depleted mice","volume":"73","author":"Dovi","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0440","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.2353\/ajpath.2009.090248","article-title":"Selective and specific macrophage ablation is detrimental to wound healing in mice","volume":"175","author":"Mirza","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0445","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/wrr.12442","article-title":"Systemic depletion of macrophages in the subacute phase of wound healing reduces hypertrophic scar formation","volume":"24","author":"Zhu","year":"2016","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb0450","article-title":"Macrophage depletion impairs corneal wound healing after autologous transplantation in mice","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb0455","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0960-9822(03)00396-8","article-title":"Wound healing in the PU.1 Null mouse\u2014tissue repair is not dependent on inflammatory cells","volume":"13","author":"Martin","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0460","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/exd.12068","article-title":"Wound-associated macrophages control collagen 1alpha2 transcription during the early stages of skin wound healing","volume":"22","author":"Rodero","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0465","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.4049\/jimmunol.0903356","article-title":"Differential roles of macrophages in diverse phases of skin repair","volume":"184","author":"Lucas","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0470","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2018.08.009_bb0475","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1582-4934.2009.00926.x","article-title":"Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway","volume":"14","author":"Coscia","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0480","doi-asserted-by":"crossref","first-page":"22620","DOI":"10.1074\/jbc.M710314200","article-title":"Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue","volume":"283","author":"Stienstra","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb0485","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00403-013-1416-8","article-title":"NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents","volume":"306","author":"Babalola","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2014.01.003","article-title":"FibromiRs: translating molecular discoveries into new anti-fibrotic drugs","volume":"35","author":"Pottier","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb0495","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.07.025","article-title":"Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis","volume":"64","author":"Cheng","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0500","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","article-title":"MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4","volume":"24","author":"He","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.addr.2018.08.009_bb0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00403-011-1178-0","article-title":"MicroRNA-146a modulates TGF-beta1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4","volume":"304","author":"Liu","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0510","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.1016\/S0002-9610(03)00296-4","article-title":"Understanding the role of immune regulation in wound healing","volume":"187","author":"Park","year":"2004","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb0525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cytogfr.2015.12.002","article-title":"New insights into CD4(+) T cell abnormalities in systemic sclerosis","volume":"28","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.addr.2018.08.009_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb0535","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/icb.2008.106","article-title":"Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance","volume":"87","author":"Wang","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0540","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cm.20133","article-title":"Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation","volume":"63","author":"Redd","year":"2006","journal-title":"Cell Motil. Cytoskeleton"},{"key":"10.1016\/j.addr.2018.08.009_bb0545","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbalip.2014.01.008","article-title":"TLR2\/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts","volume":"1841","author":"Hamidi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2018.08.009_bb0550","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1242\/jcs.032235","article-title":"Analysis of WASp function during the wound inflammatory response\u2014live-imaging studies in zebrafish larvae","volume":"121","author":"Cvejic","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb0555","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cellsig.2009.02.007","article-title":"Differential requirement for MEK\/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption","volume":"21","author":"Samarakoon","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.addr.2018.08.009_bb0560","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/BOR.0b013e328356d9f6","article-title":"Lipids and eicosanoids in fibrosis: emerging targets for therapy","volume":"24","author":"Castelino","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0565","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/1529-0131(200108)44:8<1865::AID-ART325>3.0.CO;2-M","article-title":"Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: A newly identified pathway to skin inflammation in systemic sclerosis","volume":"44","author":"Kowal-Bielecka","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb0570","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1126\/science.6254151","article-title":"Prostaglandins, arachidonic acid, and inflammation","volume":"210","author":"Kuehl","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.addr.2018.08.009_bb0575","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1073\/pnas.1203127109","article-title":"Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis","volume":"109","author":"Oyoshi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.08.009_bb0580","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1165\/rcmb.2013-0009OC","article-title":"Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation","volume":"49","author":"Ochkur","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0585","doi-asserted-by":"crossref","first-page":"H762","DOI":"10.1152\/ajpheart.00880.2010","article-title":"Terutroban, a thromboxane\/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis","volume":"300","author":"Gelosa","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.addr.2018.08.009_bb0590","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.3390\/ijms150916083","article-title":"Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications","volume":"15","author":"Seegmiller","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb0595","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(03)15279-8","article-title":"Health of thalidomide victims and their progeny","volume":"363","author":"McBride","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2018.08.009_bb0600","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-4362.1980.tb00342.x","article-title":"The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide","volume":"19","author":"Sheskin","year":"1980","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0605","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0190-9622(84)80458-2","article-title":"Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocytes and monocytes","volume":"11","author":"Barnhill","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0610","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bcp.2013.02.038","article-title":"Thalidomide inhibits fibronectin production in TGF-beta1-treated normal and keloid fibroblasts via inhibition of the p38\/Smad3 pathway","volume":"85","author":"Liang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2018.08.009_bb0615","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/790203","article-title":"Hyaluronan's role in fibrosis: a pathogenic factor or a passive player?","volume":"2015","author":"Albeiroti","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2018.08.009_bb0620","first-page":"776","article-title":"Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis","volume":"30","author":"Catanoso","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0625","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2006.10.047","article-title":"Successful treatment with infliximab in a patient with Diffuse Subretinal Fibrosis syndrome","volume":"143","author":"Adan","year":"2007","journal-title":"Am J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.addr.2018.08.009_bb0630","first-page":"503","article-title":"Subcutaneous administration of infliximab-attenuated silica-induced lung fibrosis","volume":"31","author":"Zhang","year":"2018","journal-title":"Int. J. Occup. Med. Environ. Health"},{"key":"10.1016\/j.addr.2018.08.009_bb0635","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition","volume":"122","author":"Vassallo","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.08.009_bb0640","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archdermatol.2010.120","article-title":"Treatment of recalcitrant generalized morphea with infliximab","volume":"146","author":"Diab","year":"2010","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0645","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/18743129014090100030","article-title":"A case report of successful treatment of recalcitrant childhood localized scleroderma with infliximab and leflunomide","volume":"9","author":"Ferguson","year":"2015","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.addr.2018.08.009_bb0650","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2008.096123","article-title":"An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis","volume":"68","author":"Denton","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb0655","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1469-185X.1961.tb01596.x","article-title":"Biological functions of collagen","volume":"36","author":"Harkness","year":"1961","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.addr.2018.08.009_bb0660","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1524-475X.2010.00662.x","article-title":"Cellular\/extracellular matrix cross-talk in scar evolution and control","volume":"19","author":"Widgerow","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb0665","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/wound.2011.0321","article-title":"Biomechanics of scar tissue and uninjured skin","volume":"2","author":"Corr","year":"2013","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.addr.2018.08.009_bb0670","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nprot.2017.117","article-title":"An experimental toolbox for characterization of mammalian collagen type I in biological specimens","volume":"13","author":"Capella-Monsonis","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2018.08.009_bb0675","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-4939-7113-8_22","article-title":"Collagen quantification in tissue specimens","volume":"1627","author":"Coentro","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0680","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/jsre.1993.1132","article-title":"Regulation of collagen gene expression in keloids and hypertrophic scars","volume":"55","author":"Friedman","year":"1993","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0685","series-title":"The Collagen Family: Structure, Assembly, and Organization in the Extracellular Matrix, Connective Tissue and Its Heritable Disorders","first-page":"159","author":"Kielty","year":"2003"},{"key":"10.1016\/j.addr.2018.08.009_bb0690","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00726-008-0190-y","article-title":"Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications","volume":"36","author":"Collighan","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.addr.2018.08.009_bb0695","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/jbm.a.32383","article-title":"An in situ and in vitro investigation for the transglutaminase potential in tissue engineering","volume":"92","author":"Zeugolis","year":"2010","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2018.08.009_bb0700","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0838.2005.00464.x","article-title":"Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise","volume":"15","author":"Avery","year":"2005","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.addr.2018.08.009_bb0705","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1089\/ten.tea.2016.0415","article-title":"Collagen cross-linking: biophysical, biochemical, and biological response analysis","volume":"23","author":"Delgado","year":"2017","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.addr.2018.08.009_bb0710","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1006\/bbrc.2001.4257","article-title":"Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid","volume":"280","author":"Naitoh","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2018.08.009_bb0715","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1524-475X.2009.00533.x","article-title":"Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis","volume":"17","author":"Verhaegen","year":"2009","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb0720","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1163\/156856208784909345","article-title":"Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical","volume":"19","author":"Occleston","year":"2008","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2018.08.009_bb0725","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","volume":"43","author":"Berman","year":"2017","journal-title":"Dermatol. Surg."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2018.08.009_bb0730","first-page":"s10","article-title":"Mechanisms of pathological scarring: role of myofibroblasts and current developments","volume":"19","author":"Sarrazy","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb0735","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/jsre.1995.1074","article-title":"Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-\u03b3","volume":"58","author":"Harrop","year":"1995","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0740","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1524-4725.2010.01759.x","article-title":"The effect of combined steroid and calcium channel blocker injection on human hypertrophic scars in animal model: a new strategy for the treatment of hypertrophic scars","volume":"36","author":"Yang","year":"2010","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb0745","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/07853890801986594","article-title":"Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets","volume":"40","author":"Myllyharju","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0750","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/jm061010z","article-title":"Potent and selective nonpeptidic inhibitors of procollagen C-proteinase","volume":"50","author":"Fish","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb0755","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1016\/j.bmcl.2008.10.036","article-title":"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents","volume":"18","author":"Bailey","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.08.009_bb0760","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/exd.12719","article-title":"Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb0765","doi-asserted-by":"crossref","first-page":"20922","DOI":"10.1038\/srep20922","article-title":"Co-transfection of decorin and interleukin-10 modulates pro-fibrotic extracellular matrix gene expression in human tenocyte culture","volume":"6","author":"Abbah","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.08.009_bb0770","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0775","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-291X(73)90961-3","article-title":"The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen","volume":"52","author":"Berg","year":"1973","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2018.08.009_bb0780","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF02618433","article-title":"Inhibition of collagen synthesis by alpha, alpha1-dipyridyl in human skin fibroblasts in culture","volume":"9","author":"Switzer","year":"1973","journal-title":"In Vitro"},{"key":"10.1016\/j.addr.2018.08.009_bb0785","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2480625","article-title":"Pyridinedicarboxylates, the first mechanism-derived inhibitors for prolyl 4-hydroxylase, selectively suppress cellular hydroxyprolyl biosynthesis. Decrease in interstitial collagen and Clq secretion in cell culture","volume":"248","author":"Tschank","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2018.08.009_bb0790","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1016\/S0021-9258(19)38903-3","article-title":"Specific inactivation of prolyl 4-hydroxylase and inhibition of collagen synthesis by oxaproline-containing peptides in cultured human skin fibroblasts","volume":"265","author":"Karvonen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb0795","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00210-013-0836-5","article-title":"The mechanism of hydralazine-induced collagen biosynthesis in cultured fibroblasts","volume":"386","author":"Karna","year":"2013","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.addr.2018.08.009_bb0800","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/acschembio.5b00749","article-title":"Selective Inhibition of Collagen Prolyl 4-Hydroxylase in Human Cells","volume":"11","author":"Vasta","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0805","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.RES.0000134924.89412.70","article-title":"Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases","volume":"95","author":"Knowles","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0810","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jnr.20862","article-title":"Hydralazine rescues PC12 cells from acrolein-mediated death","volume":"84","author":"Liu-Snyder","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"11","key":"10.1016\/j.addr.2018.08.009_bb0815","first-page":"CD004934","article-title":"Hydralazine for essential hypertension","author":"Kandler","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2018.08.009_bb0820","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2015.05.160","article-title":"Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review","volume":"196","author":"Farag","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2018.08.009_bb0825","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/jbm.a.34648","article-title":"Transient inhibition of connective tissue infiltration and collagen deposition into porous poly(lactic-co-glycolic acid) discs","volume":"101","author":"Love","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2018.08.009_bb0830","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.bmc.2015.05.003","article-title":"Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates","volume":"23","author":"Vasta","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb0835","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1039\/c3ib40082d","article-title":"Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting","volume":"5","author":"Lim","year":"2013","journal-title":"Integr. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0840","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/wrr.12463","article-title":"Combination of ciclopirox olamine and sphingosine-1-phosphate as granulation enhancer in diabetic wounds","volume":"24","author":"Lim","year":"2016","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb0845","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.yexcr.2006.07.013","article-title":"Functional diversity of lysyl hydroxylase 2 in collagen synthesis of human dermal fibroblasts","volume":"312","author":"Wu","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0850","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.matbio.2005.04.002","article-title":"Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: implications for collagen cross-linking and treatment of fibrosis","volume":"24","author":"Zuurmond","year":"2005","journal-title":"Matrix Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0855","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00200483","article-title":"Effect of a lysyl hydroxylase inhibitor, minoxidil, on ultrastructure and behavior of cultured rabbit subconjunctival fibroblasts","volume":"233","author":"Saika","year":"1995","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2018.08.009_bb0860","doi-asserted-by":"crossref","first-page":"19059","DOI":"10.1074\/jbc.272.30.19059","article-title":"Transforming growth factor-beta regulation of bone morphogenetic protein-1\/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes","volume":"272","author":"Lee","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb0865","series-title":"Sulfonamide Hydroxamates","author":"Roche","year":"2000"},{"key":"10.1016\/j.addr.2018.08.009_bb0870","series-title":"PCP Inhibitors","author":"Roche","year":"2000"},{"key":"10.1016\/j.addr.2018.08.009_bb0875","series-title":"Ox(adi)azolyl-Hydroxamic Acids Useful as PCP Inhibitors","author":"P. Ltd","year":"2001"},{"key":"10.1016\/j.addr.2018.08.009_bb0880","series-title":"3-Ox(adi)azolylpropanohydroxamic Acids Useful as Procollagen c-Proteinase Inhibitors","author":"P. Ltd","year":"2002"},{"key":"10.1016\/j.addr.2018.08.009_bb0885","series-title":"3-Heterocyclylpropanohydroxamic Acid pcp Inhibitors","author":"P. Ltd","year":"2002"},{"key":"10.1016\/j.addr.2018.08.009_bb0890","series-title":"3-Heterocyclylpropanohydroxamic Acid as Procollagen C-Proteinase Inhibitors","author":"P. Ltd","year":"2002"},{"key":"10.1016\/j.addr.2018.08.009_bb0895","series-title":"Phosphinate Peptide Analogues for the Treatment of Fibrotic Disorders","author":"AG","year":"2000"},{"key":"10.1016\/j.addr.2018.08.009_bb0900","series-title":"N-Substituted Arylsulfonylamino Hydroxamic Acids Useful as Inhibitors of PCP and for Treating or Preventing Disorders Related to Unregulated Collagen Production","author":"FibroGen","year":"2000"},{"key":"10.1016\/j.addr.2018.08.009_bb0905","series-title":"Hydantoin PCP Inhibitors","author":"FibroGen","year":"2001"},{"key":"10.1016\/j.addr.2018.08.009_bb0910","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/ten.teb.2014.0290","article-title":"To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices","volume":"21","author":"Delgado","year":"2015","journal-title":"Tissue Eng. B Rev."},{"key":"10.1016\/j.addr.2018.08.009_bb0915","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14728222.2016.1151003","article-title":"Lysyl oxidase isoforms and potential therapeutic opportunities for fibrosis and cancer","volume":"20","author":"Trackman","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.addr.2018.08.009_bb0920","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.patbio.2004.12.033","article-title":"Lysyl oxidase in development, aging and pathologies of the skin","volume":"53","author":"Szauter","year":"2005","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183013","article-title":"Targeting lysyl oxidase reduces peritoneal fibrosis","volume":"12","author":"Harlow","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb0930","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2016.01.012","article-title":"The lysyl oxidase inhibitor (beta-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats","volume":"92","author":"Martinez-Martinez","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2018.08.009_bb0935","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s10620-016-4254-7","article-title":"Targeting hepatic fibrosis in autoimmune hepatitis","volume":"61","author":"Montano-Loza","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb0940","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase\u2013like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Barry-Hamilton","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb0945","doi-asserted-by":"crossref","first-page":"36341","DOI":"10.1074\/jbc.M003362200","article-title":"Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen","volume":"275","author":"Giampuzzi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb0950","series-title":"Plant Nonprotein Amino and Imino Acids: Biological, Biochemical, and Toxicological Properties","article-title":"Toxic constituents and their related metabolites","author":"Rosenthal","year":"2003"},{"key":"10.1016\/j.addr.2018.08.009_bb0955","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/15287399209531680","article-title":"In vitro and in vivo inhibition of lysyl oxidase by aminopropionitriles","volume":"37","author":"Wilmarth","year":"1992","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.addr.2018.08.009_bb0960","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","article-title":"The myofibroblast: paradigm for a mechanically active cell","volume":"43","author":"Hinz","year":"2010","journal-title":"J. Biomech."},{"key":"10.1016\/j.addr.2018.08.009_bb0965","first-page":"56","article-title":"Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar","volume":"146","author":"Desmouliere","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0970","first-page":"105","article-title":"Morphological and immunochemical differences between keloid and hypertrophic scar","volume":"145","author":"Ehrlich","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb0975","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.mvr.2008.08.007","article-title":"Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring","volume":"77","author":"Xi-Qiao","year":"2009","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb0980","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouliere","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0985","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.142.3.873","article-title":"The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1","volume":"142","author":"Serini","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013778","article-title":"PPAR\u03b3 downregulation by TGF\u00df in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis","volume":"5","author":"Wei","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb0995","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/annrheumdis-2012-202716","article-title":"A synthetic PPAR-gamma agonist triterpenoid ameliorates experimental fibrosis: PPAR-gamma-independent suppression of fibrotic responses","volume":"73","author":"Wei","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb1000","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ptr.1100","article-title":"Cellular pharmacology studies of shikonin derivatives","volume":"16","author":"Chen","year":"2002","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1005","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijmm.2015.2299","article-title":"Shikonin reduces TGF-beta1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts","volume":"36","author":"Fan","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb1010","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1096\/fj.07-8218com","article-title":"Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis","volume":"21","author":"Aarabi","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2018.08.009_bb1015","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1242\/jcs.064501","article-title":"p53 at a glance","volume":"123","author":"Brady","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb1020","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)65482-X","article-title":"Mechanical forces induce scar remodeling. Study in non-pressure-treated versus pressure-treated hypertrophic scars","volume":"155","author":"Costa","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb1025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bjps.2015.09.013","article-title":"Efficacy of custom-made pressure clips for ear keloid treatment after surgical excision","volume":"69","author":"Tanaydin","year":"2016","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1030","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hep.21792","article-title":"Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture","volume":"46","author":"Li","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2018.08.009_bb1035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb1040","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M","article-title":"Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma","volume":"28","author":"Ong","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb1045","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb1050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2466-10-3","article-title":"A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma","volume":"10","author":"Singh","year":"2010","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb1055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb1060","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","article-title":"Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis","volume":"22","author":"Akhmetshina","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2018.08.009_bb1065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/eci.11.37","article-title":"Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?","volume":"7","author":"Jungel","year":"2011","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb1070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2174\/1389557511313070006","article-title":"Histone deacetylases as targets for multiple diseases","volume":"13","author":"Sangshetti","year":"2013","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb1075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1183\/09031936.00084808","article-title":"Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?","volume":"34","author":"Wang","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.08.009_bb1080","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/art.22759","article-title":"Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis","volume":"56","author":"Huber","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb1085","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1476-5381.2009.00387.x","article-title":"The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well","volume":"158","author":"Chen","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2018.08.009_bb1090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1158\/1535-7163.317.3.3","article-title":"Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy","volume":"3","author":"Chung","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb1095","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1517\/13543784.2013.853037","article-title":"New perspectives of valproic acid in clinical practice","volume":"22","author":"Cincarova","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2018.08.009_bb1100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2018.08.009_bb1105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1476-5381.2011.01247.x","article-title":"Novel therapeutic approaches for pulmonary fibrosis","volume":"163","author":"Datta","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2018.08.009_bb1110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11926-009-0017-1","article-title":"Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis","volume":"11","author":"Hinz","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.addr.2018.08.009_bb1115","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.1038\/ncomms9574","article-title":"The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis","volume":"6","author":"Nakasaki","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2018.08.009_bb1120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/dvg.1020140309","article-title":"Rapid induction and clearance of TGF beta 1 is an early response to wounding in the mouse embryo","volume":"14","author":"Martin","year":"1993","journal-title":"Dev. Genet."},{"key":"10.1016\/j.addr.2018.08.009_bb1125","first-page":"216","article-title":"Studies of transforming growth factors beta 1\u20133 and their receptors I and II in fibroblast of keloids and hypertrophic scars","volume":"85","author":"Bock","year":"2005","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.addr.2018.08.009_bb1130","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1038\/sj.jid.5700951","article-title":"A role for TGF-beta1-induced cellular responses during wound healing of the non-scarring early human fetus?","volume":"127","author":"Rolfe","year":"2007","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1523-1747.1998.00339.x","article-title":"The cutaneous microfibrillar apparatus contains latent transforming growth factor-beta binding protein-1 (LTBP-1) and is a repository for latent TGF-beta1","volume":"111","author":"Raghunath","year":"1998","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BCR.0b013e3181a28ddb","article-title":"Transforming growth factor-beta and angiotensin in fibrosis and burn injuries","volume":"30","author":"Gabriel","year":"2009","journal-title":"J. Burn Care Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1145","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biocel.2007.11.026","article-title":"The role of proteases in transforming growth factor-\u03b2 activation","volume":"40","author":"Jenkins","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb1150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/0192623311416259","article-title":"Induction of heart valve lesions by small-molecule ALK5 inhibitors","volume":"39","author":"Anderton","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb1155","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGFbeta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.08.009_bb1160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb03205.x","article-title":"Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta","volume":"995","author":"Roberts","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb1165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.bjps.2006.05.007","article-title":"Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts","volume":"60","author":"Wang","year":"2007","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.0022-202x.2001.01690.x","article-title":"Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts","volume":"118","author":"McGaha","year":"2002","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.surg.2011.06.022","article-title":"Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model","volume":"150","author":"Maciver","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.addr.2018.08.009_bb1180","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"163","author":"McCormick","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb1185","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/01.TA.0000114087.46566.EB","article-title":"Suppression of transforming growth factor beta\/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars","volume":"57","author":"Phan","year":"2004","journal-title":"J. Trauma"},{"key":"10.1016\/j.addr.2018.08.009_bb1190","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.TA.0000030630.72836.32","article-title":"Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring","volume":"54","author":"Phan","year":"2003","journal-title":"J. Trauma"},{"key":"10.1016\/j.addr.2018.08.009_bb1195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.0022-202X.2005.23859.x","article-title":"Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis","volume":"125","author":"Santiago","year":"2005","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0625.2010.01186.x","article-title":"Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report","volume":"20","author":"Tan","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmp018","article-title":"Regulation of TGF-beta signaling by Smad7","volume":"41","author":"Yan","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.addr.2018.08.009_bb1210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2230.2007.02636.x","article-title":"Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts","volume":"33","author":"Qi","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1215","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00403-010-1114-8","article-title":"Asiaticoside suppresses collagen expression and TGF-beta\/Smad signaling through inducing Smad7 and inhibiting TGF-betaRI and TGF-betaRII in keloid fibroblasts","volume":"303","author":"Tang","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.burns.2011.08.013","article-title":"Effect of tetrandrine on the TGF-beta-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro","volume":"38","author":"Zunwen","year":"2012","journal-title":"Burns"},{"key":"10.1016\/j.addr.2018.08.009_bb1225","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archderm.1990.01670340047006","article-title":"A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings","volume":"126","author":"Granstein","year":"1990","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1230","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archotol.1990.01870100053011","article-title":"Intralesional interferon gamma treatment for keloids and hypertrophic scars","volume":"116","author":"Larrabee","year":"1990","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1235","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2174\/092986707782794005","article-title":"Mannose 6-phosphate receptor targeting and its applications in human diseases","volume":"14","author":"Gary-Bobo","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb1240","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.jid.5701104","article-title":"Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts","volume":"128","author":"Thielitz","year":"2008","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jss.2003.08.242","article-title":"Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds","volume":"120","author":"Ono","year":"2004","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-009-0983-1","article-title":"Topical tamoxifen therapy in hypertrophic scars or keloids in burns","volume":"302","author":"Gragnani","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1255","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1524-4725.2010.01526.x","article-title":"Evaluating tamoxifen effect in the prevention of hypertrophic scars following surgical incisions","volume":"36","author":"Mousavi","year":"2010","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0846.2010.00479.x","article-title":"Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis","volume":"17","author":"Gisquet","year":"2011","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.addr.2018.08.009_bb1265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1534734608322983","article-title":"Avotermin: a novel antiscarring agent","volume":"7","author":"Durani","year":"2008","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.addr.2018.08.009_bb1270","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(09)60322-6","article-title":"Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I\/II studies","volume":"373","author":"Ferguson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2018.08.009_bb1275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PRS.0b013e318217429b","article-title":"Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial","volume":"128","author":"So","year":"2011","journal-title":"Plast. Reconstr. Surg."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2018.08.009_bb1280","first-page":"s38","article-title":"Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring","volume":"19","author":"Occleston","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1285","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14728222.2012.708339","article-title":"MicroRNA-29: a potential therapeutic target for systemic sclerosis","volume":"16","author":"Peng","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.addr.2018.08.009_bb1290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00403-013-1410-1","article-title":"The role of microRNAs in skin fibrosis","volume":"305","author":"Babalola","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1295","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/bm8006852","article-title":"Design of a synthetic collagen-binding peptidoglycan that modulates collagen fibrillogenesis","volume":"9","author":"Paderi","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2018.08.009_bb1300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022139","article-title":"Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring","volume":"6","author":"Stuart","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb1305","first-page":"623","article-title":"Role of caveolin-1 in the pathogenesis of tissue fibrosis by keloid-derived fibroblasts in vitro","volume":"164","author":"Zhang","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1310","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1002\/jps.22087","article-title":"Internalization and intracellular trafficking of a PTD-conjugated anti-fibrotic peptide, AZX100, in human dermal keloid fibroblasts","volume":"99","author":"Flynn","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb1315","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/jid.2008.264","article-title":"Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts","volume":"129","author":"Lopes","year":"2009","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14712598.2012.634793","article-title":"Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications","volume":"12","author":"Goldstein","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb1325","author":"ISDIN"},{"key":"10.1016\/j.addr.2018.08.009_bb1330","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/01.TA.0000114087.46566.EB","article-title":"Suppression of transforming growth factor beta\/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars","volume":"57","author":"Phan","year":"2004","journal-title":"J. Trauma"},{"key":"10.1016\/j.addr.2018.08.009_bb1335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020354","article-title":"Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice","volume":"2","author":"Liu","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.addr.2018.08.009_bb1340","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj2230587","article-title":"Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon","volume":"223","author":"Vogel","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2018.08.009_bb1345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","article-title":"Negative regulation of transforming growth factor-beta by the proteoglycan decorin","volume":"346","author":"Yamaguchi","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.08.009_bb1350","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1743-6109.2006.00150.x","article-title":"A role for decorin in cutaneous wound healing and angiogenesis","volume":"14","author":"J\u00e4rvel\u00e4inen","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1355","doi-asserted-by":"crossref","first-page":"24242","DOI":"10.1074\/jbc.M110.189365","article-title":"Decorin interacts with connective tissue growth factor (CTGF)\/CCN2 by LRR12 inhibiting its biological activity","volume":"286","author":"Vial","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb1360","doi-asserted-by":"crossref","first-page":"15767","DOI":"10.1074\/jbc.M500451200","article-title":"Decorin, a novel player in the insulin-like growth factor system","volume":"280","author":"Schonherr","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb1365","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1172\/JCI846","article-title":"Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor","volume":"101","author":"Moscatello","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.08.009_bb1370","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.200901129","article-title":"Decorin is a novel antagonistic ligand of the Met receptor","volume":"185","author":"Goldoni","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2018.08.009_bb1375","doi-asserted-by":"crossref","first-page":"21671","DOI":"10.1073\/pnas.1016233107","article-title":"Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice","volume":"107","author":"Jarvinen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.08.009_bb1380","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.burns.2008.08.021","article-title":"Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts","volume":"35","author":"Zhang","year":"2009","journal-title":"Burns"},{"key":"10.1016\/j.addr.2018.08.009_bb1385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-12-391858-1.00013-7","article-title":"Design of target-seeking antifibrotic compounds","volume":"509","author":"Jarvinen","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.addr.2018.08.009_bb1390","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/wound.2011.0299","article-title":"Targeted antiscarring therapy for tissue injuries","volume":"2","author":"Jarvinen","year":"2013","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.addr.2018.08.009_bb1395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123054","article-title":"MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar","volume":"10","author":"Kwan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb1400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.200905-0674OC","article-title":"Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis","volume":"182","author":"Maher","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.08.009_bb1405","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2018.08.009_bb1410","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0625.2007.00550.x","article-title":"mTOR as a potential therapeutic target for treatment of keloids and excessive scars","volume":"16","author":"Ong","year":"2007","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1415","doi-asserted-by":"crossref","first-page":"23166","DOI":"10.1074\/jbc.M401238200","article-title":"Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway","volume":"279","author":"Shegogue","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb1420","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.transproceed.2005.09.066","article-title":"Sirolimus inhibits platelet-derived growth factor\u2013induced collagen synthesis in rat vascular smooth muscle cells","volume":"37","author":"Park","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.addr.2018.08.009_bb1425","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/jid.2012.483","article-title":"Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity","volume":"133","author":"Syed","year":"2013","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12079-009-0037-7","article-title":"Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?","volume":"3","author":"Leask","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.addr.2018.08.009_bb1435","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.30074","article-title":"CCN2 is required for bleomycin-induced skin fibrosis in mice","volume":"63","author":"Liu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb1440","author":"Fibrogen"},{"key":"10.1016\/j.addr.2018.08.009_bb1445","author":"Fibrogen"},{"key":"10.1016\/j.addr.2018.08.009_bb1450","unstructured":"Fibrogen, Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD) (DMD), ClinicalTrials.gov [Internet], 2015."},{"key":"10.1016\/j.addr.2018.08.009_bb1455","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-017-1356-3","article-title":"Anti-connective tissue growth factor (CTGF\/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis","volume":"19","author":"Makino","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb1460","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1524-4725.2012.02345.x","article-title":"A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid\/hypertrophic scar excision","volume":"38","author":"Hayashi","year":"2012","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1465","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1524-4725.2011.02137.x","article-title":"Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids","volume":"38","author":"Sadeghinia","year":"2012","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-4632.2008.03426.x","article-title":"Effects of interferon-\u03b12b on keloid treatment with triamcinolone acetonide intralesional injection","volume":"47","author":"Lee","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1475","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"13","key":"10.1016\/j.addr.2018.08.009_bb1480","doi-asserted-by":"crossref","first-page":"e1704324","DOI":"10.1002\/adma.201704324","article-title":"Advancements and challenges in multidomain multicargo delivery vehicles","volume":"30","author":"Pugliese","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2018.08.009_bb1485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/wound.2013.0485","article-title":"Extracellular matrix reorganization during wound healing and its impact on abnormal scarring","volume":"4","author":"Xue","year":"2015","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"10.1016\/j.addr.2018.08.009_bb1490","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/PRS.0b013e3181c82dd5","article-title":"The most current algorithms for the treatment and prevention of hypertrophic scars and keloids","volume":"125","author":"Ogawa","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1495","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006534-196609000-00005","article-title":"The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide","volume":"38","author":"Ketchum","year":"1966","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1500","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-198800365-00005","article-title":"Side-effects of topical corticosteroids and their prevention","volume":"36","author":"Takeda","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2018.08.009_bb1505","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.12588","article-title":"Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature","volume":"169 Suppl 3","author":"Ud-Din","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1510","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1479-666X(07)80045-X","article-title":"Current use of steroids in management of abnormal raised skin scars","volume":"5","author":"Jalali","year":"2007","journal-title":"Surgeon"},{"key":"10.1016\/j.addr.2018.08.009_bb1515","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00266-008-9152-8","article-title":"Intralesional triamcinolone acetonide for keloid treatment: a systematic review","volume":"32","author":"Hochman","year":"2008","journal-title":"Aesthet. Plast. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1520","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2012-202275","article-title":"Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling","volume":"72","author":"Distler","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb1525","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.bjps.2013.06.004","article-title":"A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro","volume":"66","author":"Huang","year":"2013","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1530","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12262-011-0399-y","article-title":"A comparative clinical study on role of 5-flurouracil versus triamcinolone in the treatment of keloids","volume":"74","author":"Saha","year":"2012","journal-title":"Indian J. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1535","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1524-475X.2012.00862.x","article-title":"Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids","volume":"21","author":"Syed","year":"2013","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1540","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1590\/abd1806-4841.20131802","article-title":"Results of a combination of bleomycin and triamcinolone acetonide in the treatment of keloids and hypertrophic scars","volume":"88","author":"Camacho-Martinez","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1545","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-4632.2005.02633.x","article-title":"Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study","volume":"44","author":"Saray","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1550","doi-asserted-by":"crossref","first-page":"61e","DOI":"10.1097\/PRS.0b013e318290f698","article-title":"Histone deacetylase inhibitor reduces hypertrophic scarring in a rabbit ear model","volume":"132","author":"Diao","year":"2013","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1555","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00403-011-1140-1","article-title":"Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts","volume":"303","author":"Diao","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1560","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cyto.2012.12.018","article-title":"Prognostic value of circulating levels of stem cell growth factor beta (SCGF beta) in patients with Chagas' disease and idiopathic dilated cardiomyopathy","volume":"61","author":"Wang","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.addr.2018.08.009_bb1565","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/14728222.2012.680957","article-title":"Targeting the HGF\/Met signaling pathway in cancer therapy","volume":"16","author":"Cecchi","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.addr.2018.08.009_bb1570","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clinimag.2009.07.001","article-title":"The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats","volume":"33","author":"Wang","year":"2009","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.addr.2018.08.009_bb1575","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.179.8.5504","article-title":"Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice","volume":"179","author":"Okunishi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2018.08.009_bb1580","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/rheumatology\/ker367","article-title":"Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc","volume":"51","author":"Frost","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.addr.2018.08.009_bb1585","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000342405","article-title":"Emerging signaling pathways in hepatocellular carcinoma","volume":"1","author":"Moeini","year":"2012","journal-title":"Liver Cancer"},{"key":"10.1016\/j.addr.2018.08.009_bb1590","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.ASW.0000429705.02588.f5","article-title":"Hepatocyte growth factor reduces hypertrophy of skin scar: in vivo study","volume":"26","author":"Xiao","year":"2013","journal-title":"Adv. Skin Wound Care"},{"issue":"6","key":"10.1016\/j.addr.2018.08.009_bb1595","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1186\/ar2068","article-title":"Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma","volume":"8","author":"Iwasaki","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb1600","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000637-199108000-00012","article-title":"In search of the optimal treatment of keloids: report of a series and a review of the literature","volume":"27","author":"Lawrence","year":"1991","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1605","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41038-017-0069-9","article-title":"Biomaterials and tissue engineering for scar management in wound care","volume":"5","author":"Rahimnejad","year":"2017","journal-title":"Burns Trauma"},{"key":"10.1016\/j.addr.2018.08.009_bb1610","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2217\/nnm.16.21","article-title":"Influence of porosity and pore shape on structural, mechanical and biological properties of poly -caprolactone electro-spun fibrous scaffolds","volume":"11","author":"Fuller","year":"2016","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.addr.2018.08.009_bb1615","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nano.2004.11.008","article-title":"Significance of synthetic nanostructures in dictating cellular response","volume":"1","author":"Yim","year":"2005","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2018.08.009_bb1620","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0142-9612(02)00353-8","article-title":"Silk-based biomaterials","volume":"24","author":"Altman","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.08.009_bb1625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2004.02.047","article-title":"The inflammatory responses to silk films in vitro and in vivo","volume":"26","author":"Meinel","year":"2005","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.addr.2018.08.009_bb1630","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijpharm.2014.12.067","article-title":"Silk fibroin\/gelatin electrospun nanofibrous dressing functionalized with astragaloside IV induces healing and anti-scar effects on burn wound","volume":"479","author":"Shan","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2018.08.009_bb1635","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jep.2011.11.035","article-title":"The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo","volume":"139","author":"Chen","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.addr.2018.08.009_bb1640","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.msec.2014.07.039","article-title":"Enhancement of skin wound healing with decellularized scaffolds loaded with hyaluronic acid and epidermal growth factor","volume":"44","author":"Su","year":"2014","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.addr.2018.08.009_bb1645","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000342200","article-title":"Hyaluronan, a ready choice to fuel regeneration: a mini-review","volume":"59","author":"Reitinger","year":"2013","journal-title":"Gerontology"},{"key":"10.1016\/j.addr.2018.08.009_bb1650","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1163\/092050611X555687","article-title":"Development of a wound dressing composed of hyaluronic acid and collagen sponge with epidermal growth factor","volume":"23","author":"Kondo","year":"2012","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.addr.2018.08.009_bb1655","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.ASW.0000418541.31366.a3","article-title":"Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery","volume":"25","author":"Demidova-Rice","year":"2012","journal-title":"Adv. Skin Wound Care"},{"key":"10.1016\/j.addr.2018.08.009_bb1660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejo\/cjp129","article-title":"Interferon-gamma-loaded collagen scaffolds reduce myofibroblast numbers in rat palatal mucosa","volume":"33","author":"Jansen","year":"2011","journal-title":"Eur. J. Orthod."},{"key":"10.1016\/j.addr.2018.08.009_bb1665","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1524-475X.1994.20107.x","article-title":"Dermal regeneration in native non-cross-linked collagen sponges with different extracellular matrix molecules","volume":"2","author":"de Vries","year":"1994","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1670","series-title":"Plastic Compaction of a Collagen Gel","author":"Brown","year":"2012"},{"key":"10.1016\/j.addr.2018.08.009_bb1675","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/SCS.0b013e31816aaaad","article-title":"Collagen scaffolds implanted in the palatal mucosa","volume":"19","author":"Jansen","year":"2008","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1680","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1177\/00220345000790100901","article-title":"Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds","volume":"79","author":"Cornelissen","year":"2000","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1685","doi-asserted-by":"crossref","first-page":"380e","DOI":"10.1097\/PRS.0b013e31823aefee","article-title":"Reconstructing large keloids with neodermis: a systematic review","volume":"129","author":"Bidic","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1690","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1067\/mjd.2003.48","article-title":"Giant right plantar keloid treated with excision and tissue-engineered allograft","volume":"48","author":"Osswald","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1695","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/SAP.0b013e31817d87cb","article-title":"Outpatient reconstruction using integra* and subatmospheric pressure","volume":"62","author":"Park","year":"2009","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1700","doi-asserted-by":"crossref","first-page":"251","DOI":"10.12968\/jowc.2007.16.6.27070","article-title":"The effects of onion extract on hypertrophic and keloid scars","volume":"16","author":"Hosnuter","year":"2007","journal-title":"J. Wound Care"},{"key":"10.1016\/j.addr.2018.08.009_bb1705","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000000348","article-title":"Intralesional cryotherapy for the treatment of keloid scars: evaluating effectiveness","volume":"3","author":"van Leeuwen","year":"2015","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"10.1016\/j.addr.2018.08.009_bb1710","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/14764172.2011.564625","article-title":"Laser scar revision: a review","volume":"13","author":"Khatri","year":"2011","journal-title":"J. Cosmet. Laser Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb1715","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PRS.0000000000002242","article-title":"A novel approach to keloid reconstruction with bilaminar dermal substitute and epidermal skin grafting","volume":"138","author":"Nguyen","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1720","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/229255031302100208","article-title":"Eradication of keloids: surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin","volume":"21","author":"Wilson","year":"2013","journal-title":"Can. J. Plast. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1746-160X-3-14","article-title":"Combination of surgical excision and custom designed silicon pressure splint therapy for keloids on the helical rim","volume":"3","author":"Sand","year":"2007","journal-title":"Head Face Med"},{"key":"10.1016\/j.addr.2018.08.009_bb1730","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.burns.2006.01.016","article-title":"A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population","volume":"32","author":"Li-Tsang","year":"2006","journal-title":"Burns"},{"key":"10.1016\/j.addr.2018.08.009_bb1735","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0190-9622(97)70113-0","article-title":"Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections","volume":"37 (","author":"Berman","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1740","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/scs.0b013e3180de62a1","article-title":"Combined surgical excision and radiation therapy for keloid treatment","volume":"18","author":"Akita","year":"2007","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1745","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/DSS.0000000000000417","article-title":"Keloid removal by shave excision with adjuvant external beam radiation therapy","volume":"41","author":"Keeling","year":"2015","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1750","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0009-9260(76)80141-9","article-title":"Keloid scars: a new method of treatment combining surgery with interstitial radiotherapy","volume":"27","author":"Malaker","year":"1976","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.addr.2018.08.009_bb1755","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2230.1982.tb02434.x","article-title":"The historical and scientific basis of cryosurgery","volume":"7","author":"Shepherd","year":"1982","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1760","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1524-475X.2005.00084.x","article-title":"Intralesional cryosurgery enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies","volume":"14","author":"Har-Shai","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1765","first-page":"825","article-title":"Updated international clinical recommendations on scar management: part 2\u2014algorithms for scar prevention and treatment","volume":"40","author":"Gold","year":"2014","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1770","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1524-4725.2009.01085.x","article-title":"Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1775","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1524-4725.2009.01258.x","article-title":"Review of fractional photothermolysis: treatment indications and efficacy","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1780","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40001-017-0269-6","article-title":"Microneedle physical contact as a therapeutic for abnormal scars","volume":"22","author":"Yeo","year":"2017","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1785","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/apt.12820","article-title":"Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar","volume":"40","author":"Karsdal","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2018.08.009_bb1790","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb1795","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/13543784.2014.913569","article-title":"Emerging therapeutic interventions for idiopathic pulmonary fibrosis","volume":"23","author":"Chakraborty","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2018.08.009_bb1800","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1038\/jid.2008.103","article-title":"Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway","volume":"128","author":"Park","year":"2008","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1805","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.carbpol.2014.05.026","article-title":"Transdermal delivery of 10,11-methylenedioxycamptothecin by hyaluronic acid based nanoemulsion for inhibition of keloid fibroblast","volume":"112","author":"Gao","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2018.08.009_bb1810","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI12020","article-title":"Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients","volume":"108","author":"Stratton","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.08.009_bb1815","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/annrheumdis-2012-201784","article-title":"Pomalidomide is effective for prevention and treatment of experimental skin fibrosis","volume":"71","author":"Weingartner","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb1820","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jdermsci.2016.04.006","article-title":"Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis","volume":"83","author":"Stenstrom","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb1825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1524-475X.2003.11106.x","article-title":"Reduction of scar formation in full-thickness wounds with topical celecoxib treatment","volume":"11","author":"Wilgus","year":"2003","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1830","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jbm.a.34413","article-title":"Reducing scar formation by regulation of IL-1 and MMP-9 expression by using sustained release of prednisolone-loaded PDLL microspheres in a murine wound model","volume":"101","author":"Wu","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2018.08.009_bb1835","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/jid.2012.486","article-title":"Xiamenmycin attenuates hypertrophic scars by suppressing local inflammation and the effects of mechanical stress","volume":"133","author":"Liu","year":"2013","journal-title":"J. Investig. Dermatol"},{"key":"10.1016\/j.addr.2018.08.009_bb1840","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2230.2009.03606.x","article-title":"c-Ski promotes skin fibroblast proliferation but decreases type I collagen: implications for wound healing and scar formation","volume":"35","author":"Liu","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1845","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2133.2012.11023.x","article-title":"FK506 inhibits the enhancing effects of transforming growth factor (TGF)-\u03b21 on collagen expression and TGF-\u03b2\/Smad signalling in keloid fibroblasts: implication for new therapeutic approach","volume":"167","author":"Wu","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1850","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1007\/s11095-013-1266-2","article-title":"Co-delivery of dexamethasone and green tea polyphenols using electrospun ultrafine fibers for effective treatment of keloid","volume":"31","author":"Li","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1855","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/art.37809","article-title":"Tropisetron suppresses collagen synthesis in skin fibroblasts via alpha7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model","volume":"65","author":"Stegemann","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2018.08.009_bb1860","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/exd.12752","article-title":"Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin","volume":"24","author":"Ohashi","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1865","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2353\/ajpath.2008.070952","article-title":"Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine","volume":"172","author":"Fernandez","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2018.08.009_bb1870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091559","article-title":"Interleukin-1\u03b2 attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-\u03b21","volume":"9","author":"Mia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.08.009_bb1875","doi-asserted-by":"crossref","first-page":"24592","DOI":"10.1074\/jbc.M115.680074","article-title":"Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair","volume":"290","author":"Li","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.08.009_bb1880","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1136\/annrheumdis-2013-204378","article-title":"Vitamin D receptor regulates TGF-beta signalling in systemic sclerosis","volume":"74","author":"Zerr","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb1885","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3346\/jkms.2010.25.4.589","article-title":"Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing","volume":"25","author":"Kim","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.addr.2018.08.009_bb1890","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1524-475X.2008.00416.x","article-title":"Antisense inhibition of connective tissue growth factor (CTGF\/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo","volume":"16","author":"Sisco","year":"2008","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2018.08.009_bb1895","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2010.137539","article-title":"The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model","volume":"70","author":"Balistreri","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2018.08.009_bb1900","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/jbm.a.35770","article-title":"Development of a nanofibrous wound dressing with an antifibrogenic properties in vitro and in vivo model","volume":"104","author":"Poormasjedi-Meibod","year":"2016","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2018.08.009_bb1905","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lsm.22120","article-title":"Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery","volume":"45","author":"Waibel","year":"2013","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.addr.2018.08.009_bb1910","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jaad.2013.06.025","article-title":"A novel hydrogel scaffold for the prevention or reduction of the recurrence of keloid scars postsurgical excision","volume":"69","author":"Berman","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1915","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/ijd.13253","article-title":"Clinical and histological results in the treatment of atrophic and hypertrophic scars using a combined method of radiofrequency, ultrasound, and transepidermal drug delivery","volume":"55","author":"Trelles","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1920","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1468-3083.2007.02390.x","article-title":"Treatment of plaque-type localized scleroderma with retinoic acid and ultraviolet A plus the photosensitizer psoralen: a case series","volume":"22","author":"Ozdemir","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.addr.2018.08.009_bb1925","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jrr\/rrv031","article-title":"Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions","volume":"56","author":"Shen","year":"2015","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.addr.2018.08.009_bb1930","first-page":"1507","article-title":"An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids","volume":"34","author":"Koc","year":"2008","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2018.08.009_bb1935","first-page":"455","article-title":"Treatment of keloid scars post-shave excision with imiquimod 5% cream: a prospective, double-blind, placebo-controlled pilot study","volume":"8","author":"Berman","year":"2009","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1940","first-page":"1005","article-title":"Improvement in atrophic acne scars using topical synthetic epidermal growth factor (EGF) serum: a pilot study","volume":"14","author":"Seidel","year":"2015","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.addr.2018.08.009_bb1945","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthet. Plast. Surg."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18302072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18302072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:46:15Z","timestamp":1759207575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X18302072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":389,"alternative-id":["S0169409X18302072"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2018.08.009","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and upcoming therapies to modulate skin scarring and fibrosis","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}